Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Colombo Bonadio

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|January 3, 2022
Perspectives on PARP Inhibitor Combinations for Ovarian CancerRenata Colombo Bonadio, Maria Del Pilar Estevez-Diz
Cancer Epidemiology|March 15, 2022
Breast cancer trends in women younger than 40 years in BrazilRenata Colombo Bonadio, Otavio Augusto Moreira, Laura Testa
Annals of Translational Medicine|January 25, 2021
Ovarian cancer risk assessment in the era of next-generation sequencingRenata Colombo Bonadio, Jéssica Rojas Crespo, Maria Del Pilar Estevez-Diz
Ecancermedicalscience|June 26, 2020
Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countriesMaria Del Pilar Estevez-Diz, Renata Colombo Bonadio, Vanessa Costa Miranda, et al.
Gynecologic Oncology Reports|August 13, 2021
Everolimus plus anastrozole for female adnexal tumor of probable Wolffian origin (FATWO) with <i>STK11</i> mutationMaria de Pilar Estevez-Diz, Renata Colombo Bonadio, Filomena Marino Carvalho, et al.
NPJ Breast Cancer|May 16, 2025
Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancerMariana Carvalho Gouveia, Mariana Scaranti, Bruna Migliavacca Zucchetti, et al.
Ecancermedicalscience|June 11, 2025
PD-1 or PD-L1 inhibitors in addition to first-line chemotherapy for endometrial cancer: an extracted individual patient data meta-analysisMariana Carvalho Gouveia, Renata Colombo Bonadio, Felippe Lazar Neto, et al.
British Journal of Cancer|November 27, 2023
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysisMateus Trinconi Cunha, Mariana Carvalho Gouveia, Felippe Lazar Neto, et al.
Cancer Treatment Reviews|August 23, 2022
Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?Renata Colombo Bonadio, Paolo Tarantino, Laura Testa, et al.
Ecancermedicalscience|November 26, 2021
Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in BrazilRenata Colombo Bonadio, Ana Paula Messias, Otavio Augusto Moreira, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|January 3, 2022
Perspectives on PARP Inhibitor Combinations for Ovarian CancerRenata Colombo Bonadio, Maria Del Pilar Estevez-Diz
Cancer Epidemiology|March 15, 2022
Breast cancer trends in women younger than 40 years in BrazilRenata Colombo Bonadio, Otavio Augusto Moreira, Laura Testa
Annals of Translational Medicine|January 25, 2021
Ovarian cancer risk assessment in the era of next-generation sequencingRenata Colombo Bonadio, Jéssica Rojas Crespo, Maria Del Pilar Estevez-Diz
Ecancermedicalscience|June 26, 2020
Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countriesMaria Del Pilar Estevez-Diz, Renata Colombo Bonadio, Vanessa Costa Miranda, et al.
Gynecologic Oncology Reports|August 13, 2021
Everolimus plus anastrozole for female adnexal tumor of probable Wolffian origin (FATWO) with <i>STK11</i> mutationMaria de Pilar Estevez-Diz, Renata Colombo Bonadio, Filomena Marino Carvalho, et al.
NPJ Breast Cancer|May 16, 2025
Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancerMariana Carvalho Gouveia, Mariana Scaranti, Bruna Migliavacca Zucchetti, et al.
Ecancermedicalscience|June 11, 2025
PD-1 or PD-L1 inhibitors in addition to first-line chemotherapy for endometrial cancer: an extracted individual patient data meta-analysisMariana Carvalho Gouveia, Renata Colombo Bonadio, Felippe Lazar Neto, et al.
British Journal of Cancer|November 27, 2023
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysisMateus Trinconi Cunha, Mariana Carvalho Gouveia, Felippe Lazar Neto, et al.
Cancer Treatment Reviews|August 23, 2022
Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?Renata Colombo Bonadio, Paolo Tarantino, Laura Testa, et al.
Ecancermedicalscience|November 26, 2021
Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in BrazilRenata Colombo Bonadio, Ana Paula Messias, Otavio Augusto Moreira, et al.
Pageof 5